These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1082 related articles for article (PubMed ID: 26838758)
1. Evaluation of role of Notch3 signaling pathway in human lung cancer cells. Hassan WA; Yoshida R; Kudoh S; Motooka Y; Ito T J Cancer Res Clin Oncol; 2016 May; 142(5):981-93. PubMed ID: 26838758 [TBL] [Abstract][Full Text] [Related]
2. Notch1 signaling controls cell proliferation, apoptosis and differentiation in lung carcinoma. Wael H; Yoshida R; Kudoh S; Hasegawa K; Niimori-Kita K; Ito T Lung Cancer; 2014 Aug; 85(2):131-40. PubMed ID: 24888228 [TBL] [Abstract][Full Text] [Related]
3. Downregulation of the TGFβ Pseudoreceptor BAMBI in Non-Small Cell Lung Cancer Enhances TGFβ Signaling and Invasion. Marwitz S; Depner S; Dvornikov D; Merkle R; Szczygieł M; Müller-Decker K; Lucarelli P; Wäsch M; Mairbäurl H; Rabe KF; Kugler C; Vollmer E; Reck M; Scheufele S; Kröger M; Ammerpohl O; Siebert R; Goldmann T; Klingmüller U Cancer Res; 2016 Jul; 76(13):3785-801. PubMed ID: 27197161 [TBL] [Abstract][Full Text] [Related]
4. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells. Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2. Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667 [TBL] [Abstract][Full Text] [Related]
6. Differential expression of inflammasomes in lung cancer cell lines and tissues. Kong H; Wang Y; Zeng X; Wang Z; Wang H; Xie W Tumour Biol; 2015 Sep; 36(10):7501-13. PubMed ID: 25910707 [TBL] [Abstract][Full Text] [Related]
7. Ascl1-induced Wnt11 regulates neuroendocrine differentiation, cell proliferation, and E-cadherin expression in small-cell lung cancer and Wnt11 regulates small-cell lung cancer biology. Tenjin Y; Kudoh S; Kubota S; Yamada T; Matsuo A; Sato Y; Ichimura T; Kohrogi H; Sashida G; Sakagami T; Ito T Lab Invest; 2019 Nov; 99(11):1622-1635. PubMed ID: 31231131 [TBL] [Abstract][Full Text] [Related]
8. Interferon regulatory factor 4 (IRF4) is overexpressed in human non‑small cell lung cancer (NSCLC) and activates the Notch signaling pathway. Qian Y; Du Z; Xing Y; Zhou T; Chen T; Shi M Mol Med Rep; 2017 Nov; 16(5):6034-6040. PubMed ID: 28849037 [TBL] [Abstract][Full Text] [Related]
9. WT1 promotes invasion of NSCLC via suppression of CDH1. Wu C; Zhu W; Qian J; He S; Wu C; Chen Y; Shu Y J Thorac Oncol; 2013 Sep; 8(9):1163-9. PubMed ID: 23945386 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of RON in small and non-small cell lung cancers. Kanteti R; Krishnaswamy S; Catenacci D; Tan YH; EL-Hashani E; Cervantes G; Husain AN; Tretiakova M; Vokes EE; Huet H; Salgia R Genes Chromosomes Cancer; 2012 Sep; 51(9):841-51. PubMed ID: 22585712 [TBL] [Abstract][Full Text] [Related]
11. Pathobiology of Notch2 in lung cancer. Motooka Y; Fujino K; Sato Y; Kudoh S; Suzuki M; Ito T Pathology; 2017 Aug; 49(5):486-493. PubMed ID: 28666642 [TBL] [Abstract][Full Text] [Related]
12. CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner. Xie S; Tu Z; Xiong J; Kang G; Zhao L; Hu W; Tan H; Tembo KM; Ding Q; Deng X; Huang J; Zhang Q Oncol Rep; 2017 Feb; 37(2):921-928. PubMed ID: 27922681 [TBL] [Abstract][Full Text] [Related]
13. Pathobiological implications of MUC4 in non-small-cell lung cancer. Majhi PD; Lakshmanan I; Ponnusamy MP; Jain M; Das S; Kaur S; Shimizu ST; West WW; Johansson SL; Smith LM; Yu F; Rolle CE; Sharma P; Carey GB; Batra SK; Ganti AK J Thorac Oncol; 2013 Apr; 8(4):398-407. PubMed ID: 23370366 [TBL] [Abstract][Full Text] [Related]
14. ZYG11A serves as an oncogene in non-small cell lung cancer and influences CCNE1 expression. Wang X; Sun Q; Chen C; Yin R; Huang X; Wang X; Shi R; Xu L; Ren B Oncotarget; 2016 Feb; 7(7):8029-42. PubMed ID: 26771237 [TBL] [Abstract][Full Text] [Related]
15. Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma. Kumamoto T; Seki N; Mataki H; Mizuno K; Kamikawaji K; Samukawa T; Koshizuka K; Goto Y; Inoue H Int J Oncol; 2016 Nov; 49(5):1870-1880. PubMed ID: 27633630 [TBL] [Abstract][Full Text] [Related]
16. Notch3 is important for TGF-β-induced epithelial-mesenchymal transition in non-small cell lung cancer bone metastasis by regulating ZEB-1. Liu L; Chen X; Wang Y; Qu Z; Lu Q; Zhao J; Yan X; Zhang H; Zhou Y Cancer Gene Ther; 2014 Sep; 21(9):364-72. PubMed ID: 25080992 [TBL] [Abstract][Full Text] [Related]
17. Small cell lung cancer, an epithelial to mesenchymal transition (EMT)-like cancer: significance of inactive Notch signaling and expression of achaete-scute complex homologue 1. Ito T; Kudoh S; Ichimura T; Fujino K; Hassan WA; Udaka N Hum Cell; 2017 Jan; 30(1):1-10. PubMed ID: 27785690 [TBL] [Abstract][Full Text] [Related]
18. Wnt3a increases the metastatic potential of non-small cell lung cancer cells in vitro in part via its upregulation of Notch3. Li C; Song G; Zhang S; Wang E; Cui Z Oncol Rep; 2015 Mar; 33(3):1207-14. PubMed ID: 25572698 [TBL] [Abstract][Full Text] [Related]
19. Notch1 controls cell invasion and metastasis in small cell lung carcinoma cell lines. Hassan WA; Yoshida R; Kudoh S; Hasegawa K; Niimori-Kita K; Ito T Lung Cancer; 2014 Dec; 86(3):304-10. PubMed ID: 25456735 [TBL] [Abstract][Full Text] [Related]
20. Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers. Konishi J; Kawaguchi KS; Vo H; Haruki N; Gonzalez A; Carbone DP; Dang TP Cancer Res; 2007 Sep; 67(17):8051-7. PubMed ID: 17804716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]